Target intelligence / Profile preview

P-fimbrial adhesin PapG (PapG) (PapG)

Target
PapG
Molecular classification
Bacterial adhesin, Lectin, Surface protein, Chaperone-usher pilus component
01

Overview

P-fimbrial adhesin PapG is a specialized lectin located at the distal tip of P pili, which are hair-like appendages expressed by uropathogenic Escherichia coli (UPEC). Its primary biological function is to mediate high-affinity binding to the Gal(alpha1-4)Gal carbohydrate moiety found on the P blood group antigens of human kidney epithelial cells [1]. This specific adherence is a prerequisite for the colonization of the upper urinary tract and is strongly associated with the pathogenesis of acute pyelonephritis and urosepsis [2]. The PapG protein exists in several molecular variants (Class I, II, and III), each with distinct receptor specificities that influence host range and tissue tropism [3]. Therapeutic interventions targeting PapG focus on anti-adhesion strategies, such as the use of small-molecule pilicides that inhibit the chaperone-usher assembly pathway or carbohydrate mimetics that block the adhesin's binding site [4]. By preventing bacterial attachment rather than killing the pathogen, these approaches aim to reduce the selective pressure for antibiotic resistance while effectively preventing infection [5]. Sources: [1] UniProt (P07110). [2] Wright et al. (2007), Structure of the PapGII adhesin-receptor complex, EMBO J. [3] Roberts et al. (1994), Molecular epidemiology of urinary tract infections, J. Infect. Dis. [4] Pinkner et al. (2006), Rationally designed pilicides and curlicides, PNAS. [5] Spaulding et al. (2017), Selective depletion of uropathogenic E. coli from the gut, Nature.

Other names
PapGP-fimbrial adhesinGal-Gal binding proteinPyelonephritis-associated pilus adhesinP-pili tip adhesin
02

Mechanism of action

Inhibition of the chaperone-usher assembly pathway or competitive blockade of the Gal(alpha1-4)Gal binding site.

03

Biological functions

Bacterial adhesionHost cell colonizationBiofilm formationInduction of inflammatory signaling
04

Disease associations

Urinary tract infectionPyelonephritisInfectionUrosepsisBacteremia
05

Safety considerations

Specificity for uropathogens over commensal floraRenal clearance of inhibitorsPotential for compensatory expression of other adhesins
06

Interacting drugs

EC73

3 more in the full profile.

07

Biomarkers

P-fimbriae expression (papG genotype/phenotype)P1 blood group antigen status

Beyond the preview

Go deeper on P-fimbrial adhesin PapG (PapG) (PapG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on P-fimbrial adhesin PapG (PapG) (PapG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call